Assessing The Healthcare Cost of Diabetic Non-Small Cell Lung Cancer Patients Compared To Non-Small Cell Lung Cancer Patients

Cancer is the second leading cause of death worldwide. Mechanisms involved in the relationship between type 2 Diabetes (T2D) and cancer is not completely understood, and even less is known about its association with Non-Small Cell Lung Cancer (NSCLC). While these systemic responses are reasonably well understood, an adequate explanation how health care utilization is impacted for patients with both T2D and NSCLC is lacking. Our objective was to investigate the cost of care for T2D patients with NSCLC.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research